MedTrace Logo

A Study to Compare Two Anti-HIV Drug Combinations

NCT00002447 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 146

Last updated 2005-06-24

No results posted yet for this study

Summary

The purpose of this study is to compare 2 anti-HIV drug combinations.

Conditions

  • HIV Infections

Interventions

DRUG

Ritonavir

DRUG

Efavirenz

DRUG

Saquinavir

Sponsors & Collaborators

Principal Investigators

  • JSG Montaner

  • Ann Collier

  • Danielle Rouleau

  • Michael Saag

  • Paul Volberding

  • Sharon Walmsley

  • Nicholas Bellos

  • Alfred Burnside

  • Stephen Follansbee

  • Joseph Gathe

  • Bruce Hathaway

  • Margaret Hoffman-Terry

  • Jazila Mantis

  • Joseph Masci

  • Mahmoud Mustafa

  • John Schrank

  • Malte Schutz

  • Leon Smith

Study Design

Purpose
TREATMENT

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-10-31

Countries

  • United States
  • Canada
  • Puerto Rico

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00002447 on ClinicalTrials.gov